ASTA Co., Ltd.
Founded in 2006 and KOSDAQ-listed in 2017, ASTA develops MALDI-TOF mass spectrometry diagnostic and industrial systems.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2006 and listed on KOSDAQ in 2017, ASTA is a company developing MALDI-TOF mass spectrometry-based diagnostic and industrial systems. It offers the MicroIDsys (LT/Elite/Cyclone) microbial identification system, the MALDI-TOF RT (NosIDsys) cancer diagnostic system, the OAsys LDI-TOF system for the display industry, the LDI-TOF Premier for battery QC, and the GM-TOF for semiconductor process inspection. It has built a microbial database covering more than 5,000 species, received Korea's Prime Minister's Award for Technology in 2016, the IR52 Jang Young Sil Award in 2022, and the Commissioner of the Korean Intellectual Property Office Award in 2024, and exports its products to markets including Taiwan.
Products & technology
- MicroIDsys (LT/Elite/Cyclone)Identification of bacterial, fungal, and mycobacterial infections
- MALDI-TOF RT (NosIDsys)Cancer diagnosis (including breast cancer)
- LDI-TOF (OAsys)Display panel quality inspection
- LDI-TOF PremierQuality control inspection for EV batteries
- GM-TOF (Gas Monitoring)Semiconductor process gas monitoring
- Sample pretreatment kits (Sepsi Kit, Mold Kit, Myco Kit)Sample pretreatment for sepsis, fungal, and mycobacterial testing
Regulatory approvals
data.go.kr17 Korean MFDS device approvals · 2013–2024
- MFDSOther Reagents, classⅠ, for clinical microbiology2024-07-30Product approval · Class 1체외 제신 24-979 호
- MFDSMicrobial identification analyzer2022-01-05Product approval · Class 1체외 제신 22-20 호
- MFDSOther Reagents, classⅠ, for clinical microbiologyRevoked2021-06-03Product approval · Class 1체외 제신 21-809 호
- MFDSOther Reagents, classⅠ, for clinical microbiology2021-06-02Product approval · Class 1체외 제신 21-803 호
- MFDSMicrobial identification analyzer2021-01-14Product approval · Class 1체외 제신 21-45 호
- MFDSOther reagent of sample preparation kit2020-11-16Product approval · Class 1체외 제신 20-1661 호
- MFDSOther Reagents, classⅠ, for clinical microbiology2020-02-20Product approval · Class 1체외 제신 20-208 호
- MFDSMicrobial identification analyzer2019-04-19Product approval · Class 1체외 제신 19-506 호
- MFDSOther Reagents, classⅠ, for clinical microbiology2019-01-22Product approval · Class 1체외 제신 19-136 호
- MFDSOther Reagents, classⅠ, for clinical microbiology2018-05-08Product approval · Class 1체외 제신 18-550 호
- MFDSOther Reagents, classⅠ, for clinical microbiology2018-01-09Product approval · Class 1체외 제신 18-33 호
- MFDSOther Reagents, classⅠ, for clinical microbiology2017-09-06Product approval · Class 1체외 제신 17-1040 호
Show 5 more
- MFDSMicrobial identification analyzer2016-11-17Product approval · Class 1체외 제신 16-1369 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistry2016-10-17Product approval · Class 1체외 제신 16-1236 호
- MFDSOther Reagents, classⅠ, for clinical microbiology2016-10-07Product approval · Class 1체외 제신 16-1212 호
- MFDSSpectrophotometer for clinical use2013-12-18Product approval · Class 1경인 체외 제신 13-608 호
- MFDSSample processing instrumentsRevoked2013-08-05Product approval · Class 1경인 체외 제신 13-334 호
R&D and key agreements
Source: DART corporate disclosureMicroIDsys LT(MALDI-TOF LT) · 세균감염 진단 · 개발완료(2015) · Built a database covering more than 5,000 bacterial species
NosIDsys(MALDI-TOF RT) · 암(유방암 등) · 개발중(2018~) · Building databases for cancers including breast cancer and preparing for regulatory approval and sales
LDI-TOF(OAsys) · 디스플레이 산업용 품질검사 · 개발완료(2019~2021) · Sales to OLED companies began in 2021
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition